Visit WTR Logo
Subscribe now

University & Research Institutions

IP policy to take centre stage as Trump visits India 

Modi cabinet approves memorandum of understanding on IP policy issues ahead of the American president’s visit next week, but it may not address the reforms multinationals are hoping for

IP policy to take centre stage as Trump visits India 
19 Feb 2020

A deep dive into global innovation landscape emphasises the need for collaboration

Working together to develop new products is becoming a new business imperative, according to Clarivate’s latest top 100 global innovators report

18 Feb 2020

IPR slump leads to fall in PTAB caseloads for top 20 US law firms

Fish and Sterne Kessler still lead, but both saw reductions in the number of reviews they handled in 2019

Latest

View all
18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

18 Feb 2020

UK Supreme Court case could have big impact on biotech IP strategies

A much-watched dispute over Regeneron transgenic mice patents will affect when and how life sciences innovators seek protection for their increasingly complex inventions Read more

17 Feb 2020

PTAB decisions may derail Taiwan company’s litigation campaign 

ITRI spinoff CyWee has been “basically bankrupted by some of the largest companies in the world”, according to its counsel in an IPR case Read more

14 Feb 2020

Five keys to successful technology licensing with the not-for-profit community

Huge amounts of innovation in the university and wider research worlds remain untapped but there are some clear tips to follow as companies search for new sources of value Read more

News

View all
14 Feb 2020

Help to choose the IP Hall of Fame inductees for 2020

Nominate someone who deserves recognition for their outstanding, long-term contribution to the IP world Read more

12 Feb 2020

Cause for concern in German patent reform proposals

Changes to the injunctive relief regime suggested by the Ministry of Justice in a recent discussion paper could significantly weaken IP owners’ rights Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

1 Feb 2020

We need better thinking on US pharma patent reforms

As the presidential race heats up - and with even self-styled Democrat centrist Michael Bloomberg now promising radical regime change - life sciences IP professionals must interject some sanity into the debate Read more

Analysis

View all
14 Feb 2020

In surprise reversal, Indonesia to scrap patent working requirement

Sweeping economic reform package backed by president Jokowi will deliver a big win for patent owners in Southeast Asia’s biggest market Read more

13 Feb 2020

Gilead suffers setback in controversial $1 billion patent dispute with US government

A loss for the Californian company in the high-profile case could lead to a more proactive IP strategy from the federal government Read more

13 Feb 2020

TSMC surge fuels increase in patenting by Taiwanese companies

Alibaba continues to outpace semiconductor players as the biggest patent filer from outside the island Read more

11 Feb 2020

Antitrust considerations now a much bigger factor in pharma patent dealmaking

Following recent forced divestments - and with growing political concern about life sciences acquisitions - the signs are that regulators will play a larger role in transactions Read more

Insights

View all
24 May 2019

IP market news highlights

Some of the major news stories carried on the IAM platform from March to mid-May. Read more

Trending

1

Cause for concern in German patent reform proposals

2

In surprise reversal, Indonesia to scrap patent working requirement

3

Five keys to successful technology licensing with the not-for-profit community

4

TSMC surge fuels increase in patenting by Taiwanese companies

5

Gilead suffers setback in controversial $1 billion patent dispute with US government

We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.